Davide D'angelo

Parma, 43124, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases.

CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases.

Journal: Pharmaceutics
Published: April 08, 2026

Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects.

Unveiling tablet structural changes: A micro computed tomography analysis of aqueous coating effects.

Journal: International journal of pharmaceutics
Published: October 18, 2024

Development of a nasal spray based on cyclodextrin/hydrophobically-modified hydroxypropyl-methyl cellulose for the prevention of viral respiratory infections.

Development of a nasal spray based on cyclodextrin/hydrophobically-modified hydroxypropyl-methyl cellulose for the prevention of viral respiratory infections.

Journal: International journal of biological macromolecules
Published: October 03, 2024

Heparin-azithromycin microparticles show anti-inflammatory effects and inhibit SARS-CoV-2 and bacterial pathogens associated to lung infections.

Heparin-azithromycin microparticles show anti-inflammatory effects and inhibit SARS-CoV-2 and bacterial pathogens associated to lung infections.

Journal: Carbohydrate polymers
Published: August 05, 2024

Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays.

Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays.

Journal: Pharmaceutics
Published: June 11, 2024

Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2.

Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: November 17, 2023

Long-acting inhaled medicines: Present and future.

Long-acting inhaled medicines: Present and future.

Journal: Advanced drug delivery reviews
Published: June 05, 2023

An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro.

An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro.

Journal: Pharmaceutics
Published: February 08, 2023

Corrigendum to "No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs" [Int. J. Pharm. 631 (2023) 122478].

Corrigendum to "No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs" [Int. J. Pharm. 631 (2023) 122478].

Journal: International journal of pharmaceutics
Published: January 28, 2023

The impact of possible improper use on the performance in vitro of NEXThaler in comparison with Ellipta inhaler.

The impact of possible improper use on the performance in vitro of NEXThaler in comparison with Ellipta inhaler.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: September 02, 2022

No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs.

No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs.

Journal: International journal of pharmaceutics
Published: August 31, 2022

Fluorescence-enabled evaluation of nasal tract deposition and coverage of pharmaceutical formulations in a silicone nasal cast using an innovative spray device.

Fluorescence-enabled evaluation of nasal tract deposition and coverage of pharmaceutical formulations in a silicone nasal cast using an innovative spray device.

Journal: Journal of advanced research
Published: February 22, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026